Neurogenetic and Epigenetic Correlates of Adolescent Predisposition to and Risk for Addictive Behaviors as a Function of Prefrontal Cortex Dysregulation

被引:28
作者
Blum, Kenneth [1 ,2 ,3 ,4 ,5 ]
Febo, Marcelo [1 ,2 ]
Smith, David E. [3 ,6 ]
Roy, A. Kenison, III [7 ]
Demetrovics, Zsolt [8 ]
Cronje, Frans J. [9 ]
Femino, John [10 ]
Agan, Gozde [3 ]
Fratantonio, James L. [11 ]
Pandey, Subhash C. [12 ,13 ]
Badgaiyan, Rajendra D. [14 ]
Gold, Mark S. [1 ,2 ,4 ]
机构
[1] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA
[3] Domin Diagnost LLC, Div Addict Serv, North Kingstown, RI USA
[4] Malibu Beach Recovery Ctr, Dept Addict Res & Therapy, Malibu Beach, CA USA
[5] Univ Vermont, Coll Med, Dept Psychiat, Human Integrat Serv & Translat Sci, Burlington, VT USA
[6] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA
[7] Behav Med Corp, Metairie, LA USA
[8] Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addict, Budapest, Hungary
[9] Univ Stellenbosch, Cape Town, South Africa
[10] Meadows Edge Recovery Ctr, Dept Clin Med, North Kingston, RI USA
[11] Domin Diagnost LLC, Div Appl Clin Res, North Kingston, RI USA
[12] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[13] Jesse Brown VA Med Ctr, Chicago, IL USA
[14] Univ Minnesota, Dept Psychiat, Coll Med, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GENETIC MODEL; RECEPTOR GENE; ALCOHOL-USE; BRAIN; POLYMORPHISMS; CONNECTIVITY; OXYTOCIN; DRD2; PSYCHOPATHOLOGY;
D O I
10.1089/cap.2014.0146
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
As addiction professionals, we are becoming increasingly concerned about preteenagers and young adults' involvement with substance abuse as a way of relieving stress and anger. The turbulent underdeveloped central nervous system, especially in the prefrontal cortex (PFC), provides impetus to not only continue important neuroimaging studies in both human and animal models, but also to encourage preventive measures and cautions embraced by governmental and social media outlets. It is well known that before people reach their 20s, PFC development is undergoing significant changes and, as such, hijacks appropriate decision making in this population. We are further proposing that early genetic testing for addiction risk alleles will offer important information that could potentially be utilized by their parents and caregivers prior to use of psychoactive drugs by these youth. Understandably, family history, parenting styles, and attachment may be modified by various reward genes, including the known bonding substances oxytocin/vasopressin, which effect dopaminergic function. Well-characterized neuroimaging studies continue to reflect region-specific differential responses to drugs and food (including other non-substance-addictive behaviors) via either "surfeit" or "deficit." With this in mind, we hereby propose a "reward deficiency solution system" that combines early genetic risk diagnosis, medical monitoring, and nutrigenomic dopamine agonist modalities to combat this significant global dilemma that is preventing our youth from leading normal productive lives, which will in turn make them happier.
引用
收藏
页码:286 / 292
页数:7
相关论文
共 76 条
  • [31] Epigenomics
    Gomase, Virendra S.
    Tagore, Somnath
    [J]. CURRENT DRUG METABOLISM, 2008, 9 (03) : 232 - 237
  • [32] Epigenetics and its implications for Psychology
    Gonzalez-Pardo, Hector
    Alvarez, Marino Perez
    [J]. PSICOTHEMA, 2013, 25 (01) : 3 - 12
  • [33] Hao Yanli, 2011, Front Psychiatry, V2, P21, DOI 10.3389/fpsyt.2011.00021
  • [34] Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: Methylphenidate vs. atomoxetine treatments
    Harvey, Roxann C.
    Jordan, Chloe J.
    Tassin, David H.
    Moody, Kayla R.
    Dwoskin, Linda P.
    Kantak, Kathleen M.
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2013, 244 : 38 - 47
  • [35] Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech
    Hill, Edward
    Han, David
    Dumouchel, Pierre
    Dehak, Najim
    Quatieri, Thomas
    Moehs, Charles
    Oscar-Berman, Marlene
    Giordano, John
    Simpatico, Thomas
    Blum, Kenneth
    [J]. PLOS ONE, 2013, 8 (07):
  • [36] Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments
    Jordan, Chloe J.
    Harvey, Roxann C.
    Baskin, Britahny B.
    Dwoskin, Linda P.
    Kantak, Kathleen M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2014, 140 : 25 - 32
  • [37] Pathological Internet use among European adolescents: psychopathology and self-destructive behaviours
    Kaess, Michael
    Durkee, Tony
    Brunner, Romuald
    Carli, Vladimir
    Parzer, Peter
    Wasserman, Camilla
    Sarchiapone, Marco
    Hoven, Christina
    Apter, Alan
    Balazs, Judit
    Balint, Maria
    Bobes, Julio
    Cohen, Renaud
    Cosman, Doina
    Cotter, Padraig
    Fischer, Gloria
    Floderus, Birgitta
    Iosue, Miriam
    Haring, Christian
    Kahn, Jean-Pierre
    Musa, George J.
    Nemes, Bogdan
    Postuvan, Vita
    Resch, Franz
    Saiz, Pilar A.
    Sisask, Merike
    Snir, Avigal
    Varnik, Airi
    Ziberna, Janina
    Wasserman, Danuta
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (11) : 1093 - 1102
  • [38] DRD2 C32806T Modifies the Effect of Child-Rearing Environment on Adulthood Novelty Seeking
    Keltikangas-Jarvinen, Lilsa
    Pulkki-Raback, Laura
    Elovainio, Marko
    Raitakari, Olli. T.
    Viikari, Jorma
    Lehtimaki, Terho
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B (03) : 389 - 394
  • [39] Epigenetic dynamics in psychiatric disorders: Environmental programming of neurodevelopmental processes
    Kofink, Daniel
    Boks, Marco P. M.
    Timmers, H. T. Marc
    Kas, Martien J.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (05) : 831 - 845
  • [40] Neurocircuitry of Addiction
    Koob, George F.
    Volkow, Nora D.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2010, 35 (01) : 217 - 238